These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


110 related items for PubMed ID: 8704423

  • 1. [Preliminary study on early fibrosis of chronic hepatitis B treated with Ginkgo biloba Composita].
    Li W, Dai QT, Liu ZE.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Oct; 15(10):593-5. PubMed ID: 8704423
    [Abstract] [Full Text] [Related]

  • 2. [Procollagen III and laminin in chronic viral hepatopathies].
    Montalto G, Soresi M, Aragona F, Tripi S, Carroccio A, Anastasi G, Magliarisi C, Barresi E, Notarbartolo A.
    Presse Med; 1996 Jan 20; 25(2):59-62. PubMed ID: 8745719
    [Abstract] [Full Text] [Related]

  • 3. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
    Yin SS, Wang BE, Wang TL, Jia JD, Qian LX.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug 20; 12(8):467-70. PubMed ID: 15329205
    [Abstract] [Full Text] [Related]

  • 4. Decrease in serum levels of markers of hepatic connective tissue turnover during and after treatment of chronic hepatitis B with interferon-alpha.
    Teran JC, Mullen KD, Hoofnagle JH, McCullough AJ.
    Hepatology; 1994 Apr 20; 19(4):849-56. PubMed ID: 8138256
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of serum laminin P1, procollagen-III peptides, and N-acetyl-beta-glucosaminidase for monitoring the activity of liver fibrosis.
    Schneider M, Voss B, Högemann B, Eberhardt G, Gerlach U.
    Hepatogastroenterology; 1989 Dec 20; 36(6):506-10. PubMed ID: 2693303
    [Abstract] [Full Text] [Related]

  • 6. [Comparison on efficacy in treating liver fibrosis of chronic hepatitis B between Astragalus Polygonum anti-fibrosis decoction and jinshuibao capsule].
    Chen H, Weng L.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Apr 20; 20(4):255-7. PubMed ID: 11789260
    [Abstract] [Full Text] [Related]

  • 7. [Correlation of serum markers with fibrosis staging in chronic viral hepatitis].
    Wang T, Wang B, Liu X.
    Zhonghua Bing Li Xue Za Zhi; 1998 Jun 20; 27(3):185-90. PubMed ID: 11244978
    [Abstract] [Full Text] [Related]

  • 8. [Comparison of pre- and post-treatmental hepatohistology with heavy dosage of Paeonia rubra on chronic active hepatitis caused liver fibrosis].
    Yang DG.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1994 Apr 20; 14(4):207-9, 195. PubMed ID: 7950194
    [Abstract] [Full Text] [Related]

  • 9. [Serial changes in serum levels of laminin and type III procollagen N-terminal peptide after transarterial embolization (TAE) in hepatocellular carcinoma].
    Matsuda H.
    Nihon Shokakibyo Gakkai Zasshi; 1991 Feb 20; 88(2):153-61. PubMed ID: 1851519
    [Abstract] [Full Text] [Related]

  • 10. Basement membrane-related and type III procollagen-related antigens in serum of patients with chronic viral liver disease.
    Misaki M, Shima T, Yano Y, Sumita Y, Kano U, Murata T, Watanabe S, Suzuki S.
    Clin Chem; 1990 Mar 20; 36(3):522-4. PubMed ID: 2311224
    [Abstract] [Full Text] [Related]

  • 11. Clinical significance of serum type-III procollagen aminopropeptide in hepatitis B virus-related liver diseases.
    Chang TT, Lin HC, Lee SD, Tsai YT, Lee FY, Jeng FS, Wu JC, Yeh PS, Lo KJ.
    Scand J Gastroenterol; 1989 Jun 20; 24(5):533-8. PubMed ID: 2762752
    [Abstract] [Full Text] [Related]

  • 12. Procollagen-III peptide and chronic viral C hepatitis.
    Jeffers LJ, Coelho-Little ME, Cheinquer H, Vargas C, Civantos F, Alvarez L, Reddy KR, Parker T, de Medina M, Li X.
    Am J Gastroenterol; 1995 Sep 20; 90(9):1437-40. PubMed ID: 7661165
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Determination of serum fibrosis indexes in patients with chronic hepatitis and its significance.
    Zheng M, Cai W, Weng H, Liu R.
    Chin Med J (Engl); 2003 Mar 20; 116(3):346-9. PubMed ID: 12781034
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Serum aminoterminal procollagen type-III peptide in the diagnosis of chronic hepatopathies].
    Solís-Herruzo JA, Morillas JD, Vargas J, Colina F, Castellano G, Muñoz Yagüe T, Estenoz J.
    Med Clin (Barc); 1992 May 30; 99(1):1-5. PubMed ID: 1602891
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.